The reported changes in brain morphology and functional connectivity could be a result of intervention-related changes in sleep patterns, BDNF, serotonin or depression, as revealed by a number of exploratory outcomes including general and psychological health and markers of unevoked gut–brain axis signaling. This evidence concerns the gene BDNF and depressive symptom measurement.